Trials / Conditions / Dermatomyositis, Adult Type

Dermatomyositis, Adult Type

5 registered clinical trials studyying Dermatomyositis, Adult Type.

Status	Trial	Sponsor	Phase
Completed	A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predomin NCT06433999	Priovant Therapeutics, Inc.	Phase 2
Unknown	Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis NCT05986162	Biotech Pharmaceutical Co., Ltd.	Phase 1
Unknown	Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis NCT05375435	The First Affiliated Hospital with Nanjing Medical University	Phase 4
Unknown	The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patie NCT04966884	First Affiliated Hospital Xi'an Jiaotong University	Phase 4
Completed	Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant NCT03529955	Tulane University	Phase 2